Wednesday, May 31, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | India | Dr S S Jadhav Who Helped Develop Siis Covishield Dies In Pune

Dr S.S. Jadhav, who helped develop SII’s Covishield, dies in Pune

Pune: Eminent scientist and Executive Director of Serum Institute of India (SII) Dr Suresh S. Jadhav – who was instrumental in developing the lifesaver Covishield vaccine – passed away after a prolonged illness at a private hospital late on Tuesday night. He was 72 and is survived by his wife and two children. Jadhav’s demise […]

By IANS
Updated On - 10:21 AM, Thu - 9 December 21
Dr S.S. Jadhav, who helped develop SII’s Covishield, dies in Pune
Source: IANS
whatsapp facebook twitter telegram

Pune: Eminent scientist and Executive Director of Serum Institute of India (SII) Dr Suresh S. Jadhav – who was instrumental in developing the lifesaver Covishield vaccine – passed away after a prolonged illness at a private hospital late on Tuesday night.

He was 72 and is survived by his wife and two children.

Jadhav’s demise was mourned by SII CEO Adar Poonawalla and World Health Organisation (WHO) Chief Scientist Dr Soumya Swaminathan, besides other prominent personalities.

Poonawalla said that “the Indian vaccine industry has lost a guiding light with the passing of Dr Suresh Jadhav”.

“Dr Jadhav was instrumental in setting up the Developing Countries Vaccine Manufacturing Network (DCVMN). He represented the SII on the GAVI board and was also instrumental in the liaison between the national and international regulatory authorities. He played a pivotal role in getting WHO pre-qualifications of several products,” he said.

Dr Swaminathan said: “Very sad news. Exceptional lifetime contributions to vaccine development with huge impact on lives saved.”

Born in a small village in eastern Maharashtra, Dr Jadhav completed his graduation in Pharmacy from Nagpur University and started his career with a research fellowship of the CSIR in 1970.

After spending several years in academics at Nagpur University’s Department of Pharmaceutical Sciences, University of Mumbai, SNDT Women’s University and Haffkine Institute, he joined the SII in 1979, where he became the ED in 1992.

Ranked at No 7 among the World’s 50 Most Influential People in Vaccine as surveyed by Vaccination of Terrapinn, Dr Jadhav held 2 patents in his name.

He played a pivotal role in securing WHO accreditation for various vaccines produced by the SII, which is now ranked as the global leader supplying vaccines to over 140 countries.

Dr Jadhav’s technical expertise spanned various quality control techniques and drugs pricing and served several times as Expert, and Temporary Advisor to WHO for its vaccine programmes and policies, new vaccines, new methods of vaccine testing, developing new reference standards, etc.

With his huge experience, he spearheaded the DCVMN as President (2004-2008) and was on its Steering Committee since inception in 2000, besides serving on boards of various international vaccine bodies.

He toured globally delivering lectures, attending scientific seminars or conferences, published over 60 scientific research papers, served on several Indian and international government or private academic institutes, universities, etc, and was decorated with several honours/awards all over the world.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • Covishield
  • Dr S.S. Jadhav
  • Serum Institute of India

Related News

  • Covid on rise: SII restarts Covishield manufacturing

    Covid on rise: SII restarts Covishield manufacturing

  • CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

    CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

  • Telangana urges MOHFW to release 50 lakh doses of Covishield

    Telangana urges MOHFW to release 50 lakh doses of Covishield

  • India will play a vital role in Industrial Revolution 4.0: Dharmendra Pradhan

    India will play a vital role in Industrial Revolution 4.0: Dharmendra Pradhan

  • Poonawalla woos Musk to invest in making Tesla cars in India

    Poonawalla woos Musk to invest in making Tesla cars in India

  • Covaxin, Covishield to cost Rs 225 per dose

    Covaxin, Covishield to cost Rs 225 per dose

Latest News

  • Congress slams BJP over broken statues at Mahakal temple, demands probe

    5 mins ago
  • TSPSC debars 37 candidates for recruitment exams till further orders

    15 mins ago
  • About 40 medical colleges lose recognition for non-compliance with NMC standards

    5 hours ago
  • Number of Rs 500 fake currency notes rose by 14.6 per cent: RBI

    5 hours ago
  • Opinion: AI and ethical dilemmas

    5 hours ago
  • Editorial: Mammoth task in Manipur

    6 hours ago
  • French Open: Seyboth Wild stuns Medvedev in five-set thriller

    6 hours ago
  • Tech Tok: Neuralink gets approval for human study

    6 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam